FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004563659> ?p ?o ?g. }

• W2004563659 endingPage "707" @default.
• W2004563659 startingPage "701" @default.
• W2004563659 abstract "Aim To retrospectively evaluate the efficacy of biphasic magnetic resonance imaging (MRI) of the liver with ferucarbotran-enhancement for the characterization of hepatic metastases. Materials and methods Thirty-six patients underwent MRI of the liver with separate acquisition of double-contrast enhancement consisting of gadolinium and ferucarbotran. A total of 106 focal hepatic lesions (51 metastases, 31 cysts, 23 haemangiomas, and one eosinophilic abscess) were included. Two sets of MRI were analysed: (1) ferucarbotran set: ferucarbotran-enhanced T1-weighted (T1W) dynamic imaging combined with ferucarbotran-enhanced T2∗-weighted (T2∗W) delayed imaging and (2) double set: gadolinium-enhanced T1W dynamic imaging combined with ferucarbotran-enhanced T2∗W delayed imaging. The diagnostic accuracy of the two sets was evaluated using alternative free-response receiver operating characteristic curve analysis. Sensitivity and specificity were compared using the McNemar test. The enhancement pattern of focal hepatic lesions was analysed on gadolinium and ferucarbotran-enhanced T1W dynamic imaging. Results There was no significant difference in the accuracy of characterizing hepatic metastases between the two sets. Sensitivity and specificity were not significantly different between the sets (p>0.05). Peripheral rim enhancement was exhibited in 57% of metastatic lesions on ferucarbotran-enhanced T1W dynamic imaging. The majority (96%) of hepatic haemangiomas demonstrated typical peripheral nodular enhancement with progression on ferucarbotran-enhanced T1W dynamic imaging and were easily differentiated from metastases. Conclusion Biphasic MRI of the liver with ferucarbotran-enhancement alone provided comparable diagnostic efficacy to double-contrast MRI for the characterization of hepatic metastases. To retrospectively evaluate the efficacy of biphasic magnetic resonance imaging (MRI) of the liver with ferucarbotran-enhancement for the characterization of hepatic metastases. Thirty-six patients underwent MRI of the liver with separate acquisition of double-contrast enhancement consisting of gadolinium and ferucarbotran. A total of 106 focal hepatic lesions (51 metastases, 31 cysts, 23 haemangiomas, and one eosinophilic abscess) were included. Two sets of MRI were analysed: (1) ferucarbotran set: ferucarbotran-enhanced T1-weighted (T1W) dynamic imaging combined with ferucarbotran-enhanced T2∗-weighted (T2∗W) delayed imaging and (2) double set: gadolinium-enhanced T1W dynamic imaging combined with ferucarbotran-enhanced T2∗W delayed imaging. The diagnostic accuracy of the two sets was evaluated using alternative free-response receiver operating characteristic curve analysis. Sensitivity and specificity were compared using the McNemar test. The enhancement pattern of focal hepatic lesions was analysed on gadolinium and ferucarbotran-enhanced T1W dynamic imaging. There was no significant difference in the accuracy of characterizing hepatic metastases between the two sets. Sensitivity and specificity were not significantly different between the sets (p>0.05). Peripheral rim enhancement was exhibited in 57% of metastatic lesions on ferucarbotran-enhanced T1W dynamic imaging. The majority (96%) of hepatic haemangiomas demonstrated typical peripheral nodular enhancement with progression on ferucarbotran-enhanced T1W dynamic imaging and were easily differentiated from metastases. Biphasic MRI of the liver with ferucarbotran-enhancement alone provided comparable diagnostic efficacy to double-contrast MRI for the characterization of hepatic metastases." @default.
• W2004563659 created "2016-06-24" @default.
• W2004563659 creator A5002343172 @default.
• W2004563659 creator A5004642384 @default.
• W2004563659 creator A5035033921 @default.
• W2004563659 creator A5048908880 @default.
• W2004563659 creator A5063076642 @default.
• W2004563659 creator A5067844999 @default.
• W2004563659 creator A5085242093 @default.
• W2004563659 date "2010-09-01" @default.
• W2004563659 modified "2023-09-27" @default.
• W2004563659 title "Characterization of liver metastases: the efficacy of biphasic magnetic resonance imaging with ferucarbotran-enhancement" @default.
• W2004563659 cites W1560609297 @default.
• W2004563659 cites W1975043932 @default.
• W2004563659 cites W1988089378 @default.
• W2004563659 cites W1991020905 @default.
• W2004563659 cites W1991962629 @default.
• W2004563659 cites W1994072093 @default.
• W2004563659 cites W2007467727 @default.
• W2004563659 cites W2015325450 @default.
• W2004563659 cites W2026650714 @default.
• W2004563659 cites W2042911627 @default.
• W2004563659 cites W2048379151 @default.
• W2004563659 cites W2055146083 @default.
• W2004563659 cites W2059907075 @default.
• W2004563659 cites W2061807407 @default.
• W2004563659 cites W2065243231 @default.
• W2004563659 cites W2074842500 @default.
• W2004563659 cites W209245972 @default.
• W2004563659 cites W2121536236 @default.
• W2004563659 cites W2161859610 @default.
• W2004563659 cites W2163620918 @default.
• W2004563659 doi "https://doi.org/10.1016/j.crad.2010.04.011" @default.
• W2004563659 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20696297" @default.
• W2004563659 hasPublicationYear "2010" @default.
• W2004563659 type Work @default.
• W2004563659 sameAs 2004563659 @default.
• W2004563659 citedByCount "1" @default.
• W2004563659 countsByYear W20045636592016 @default.
• W2004563659 crossrefType "journal-article" @default.
• W2004563659 hasAuthorship W2004563659A5002343172 @default.
• W2004563659 hasAuthorship W2004563659A5004642384 @default.
• W2004563659 hasAuthorship W2004563659A5035033921 @default.
• W2004563659 hasAuthorship W2004563659A5048908880 @default.
• W2004563659 hasAuthorship W2004563659A5063076642 @default.
• W2004563659 hasAuthorship W2004563659A5067844999 @default.
• W2004563659 hasAuthorship W2004563659A5085242093 @default.
• W2004563659 hasConcept C105795698 @default.
• W2004563659 hasConcept C126838900 @default.
• W2004563659 hasConcept C142724271 @default.
• W2004563659 hasConcept C143409427 @default.
• W2004563659 hasConcept C186282968 @default.
• W2004563659 hasConcept C191897082 @default.
• W2004563659 hasConcept C192562407 @default.
• W2004563659 hasConcept C2989005 @default.
• W2004563659 hasConcept C33923547 @default.
• W2004563659 hasConcept C557651011 @default.
• W2004563659 hasConcept C71924100 @default.
• W2004563659 hasConceptScore W2004563659C105795698 @default.
• W2004563659 hasConceptScore W2004563659C126838900 @default.
• W2004563659 hasConceptScore W2004563659C142724271 @default.
• W2004563659 hasConceptScore W2004563659C143409427 @default.
• W2004563659 hasConceptScore W2004563659C186282968 @default.
• W2004563659 hasConceptScore W2004563659C191897082 @default.
• W2004563659 hasConceptScore W2004563659C192562407 @default.
• W2004563659 hasConceptScore W2004563659C2989005 @default.
• W2004563659 hasConceptScore W2004563659C33923547 @default.
• W2004563659 hasConceptScore W2004563659C557651011 @default.
• W2004563659 hasConceptScore W2004563659C71924100 @default.
• W2004563659 hasIssue "9" @default.
• W2004563659 hasLocation W20045636591 @default.
• W2004563659 hasLocation W20045636592 @default.
• W2004563659 hasOpenAccess W2004563659 @default.
• W2004563659 hasPrimaryLocation W20045636591 @default.
• W2004563659 hasRelatedWork W1967287397 @default.
• W2004563659 hasRelatedWork W1970558757 @default.
• W2004563659 hasRelatedWork W2021884865 @default.
• W2004563659 hasRelatedWork W2054607356 @default.
• W2004563659 hasRelatedWork W2076089999 @default.
• W2004563659 hasRelatedWork W2084573604 @default.
• W2004563659 hasRelatedWork W2579165050 @default.
• W2004563659 hasRelatedWork W2735605977 @default.
• W2004563659 hasRelatedWork W2913624518 @default.
• W2004563659 hasRelatedWork W3118294176 @default.
• W2004563659 hasVolume "65" @default.
• W2004563659 isParatext "false" @default.
• W2004563659 isRetracted "false" @default.
• W2004563659 magId "2004563659" @default.
• W2004563659 workType "article" @default.